Maine Center for Cancer Medicine-Kennebunk

Kennebunk, Maine 04043

0 studies enrolling now · 4 studies all time

What they study most

ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Carcinoma, HER2 Positive Breast Carcinoma, Invasive Breast Carcinoma

Studies at this site

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy — Running, not enrolling
• T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial — Running, not enrolling
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Breast Cancer WEight Loss Study (BWEL Study) — Running, not enrolling